The KDM4B–CCAR1–MED1 axis is a critical regulator of osteoclast differentiation and bone homeostasis

Abstract

Bone undergoes a constant and continuous remodeling process that is tightly regulated by the coordinated and sequential actions of bone-resorbing osteoclasts and bone-forming osteoblasts. Recent studies have shown that histone demethylases are implicated in osteoblastogenesis; however, little is known about the role of histone demethylases in osteoclast formation. Here, we identified KDM4B as an epigenetic regulator of osteoclast differentiation. Knockdown of KDM4B significantly blocked the formation of tartrate-resistant acid phosphatase-positive multinucleated cells. Mice with myeloid-specific conditional knockout of KDM4B showed an osteopetrotic phenotype due to osteoclast deficiency. Biochemical analysis revealed that KDM4B physically and functionally associates with CCAR1 and MED1 in a complex. Using genome-wide chromatin immunoprecipitation (ChIP)-sequencing, we revealed that the KDM4B–CCAR1–MED1 complex is localized to the promoters of several osteoclast-related genes upon receptor activator of NF-κB ligand stimulation. We demonstrated that the KDM4B–CCAR1–MED1 signaling axis induces changes in chromatin structure (euchromatinization) near the promoters of osteoclast-related genes through H3K9 demethylation, leading to NF-κB p65 recruitment via a direct interaction between KDM4B and p65. Finally, small molecule inhibition of KDM4B activity impeded bone loss in an ovariectomized mouse model. Taken together, our findings establish KDM4B as a critical regulator of osteoclastogenesis, providing a potential therapeutic target for osteoporosis.

References

[1] Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simoes MJ, Cerri PS. Biology of bone tissue: structure, function, and factors that influence bone cells. BioMed Res. Int., 2015, 2015: 421746

[2] Sobacchi C, Schulz A, Coxon FP, Villa A, Helfrich MH. Osteopetrosis: genetics, treatment and new insights into osteoclast function. Nat. Rev. Endocrinol., 2013, 9: 522-536

[3] Han Y, You X, Xing W, Zhang Z, Zou W. Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts. Bone Res., 2018, 6: 16

[4] Boyce BF et al. Roles for NF-kappa B and c-Fos in osteoclasts. J. Bone Min. Metab., 2005, 23: 11-15

[5] Kim JH, Kim N. Regulation of NFATc1 in osteoclast differentiation. J. Bone Metab., 2014, 21: 233-241

[6] Lee NK et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood, 2005, 106: 852-859

[7] Feng X, McDonald JM. Disorders of bone remodeling. Annu. Rev. Pathol., 2011, 6: 121-145

[8] Faulkner, B., Astleford, K. & Mansky, K. C. Regulation of osteoclast differentiation and skeletal maintenance by histone deacetylases. Molecules 24, 1355 (2019).

[9] Gordon JA et al. Epigenetic regulation of early osteogenesis and mineralized tissue formation by a HOXA10-PBX1-associated complex. Cells Tissues Organs, 2011, 194: 146-150

[10] Husain A, Jeffries MA. Epigenetics and bone remodeling. Curr. Osteoporos. Rep., 2017, 15: 450-458

[11] Park-Min KH. Epigenetic regulation of bone cells. Connect. Tissue Res., 2017, 58: 76-89

[12] Yi, S. J. et al. Bone remodeling: histone modifications as fate determinants of bone cell differentiation. Int. J. Mol. Sci. 20, 3147 (2019).

[13] Blixt NC et al. Class II and IV HDACs function as inhibitors of osteoclast differentiation. PLoS ONE, 2017, 12

[14] Fang C et al. Cutting edge: EZH2 promotes osteoclastogenesis by epigenetic silencing of the negative regulator IRF8. J. Immunol., 2016, 196: 4452-4456

[15] Huh JE et al. Sirtuin 3 (SIRT3) maintains bone homeostasis by regulating AMPK-PGC-1beta axis in mice. Sci. Rep., 2016, 6

[16] Jin Z, Wei W, Huynh H, Wan Y. HDAC9 inhibits osteoclastogenesis via mutual suppression of PPARgamma/RANKL signaling. Mol. Endocrinol., 2015, 29: 730-738

[17] Kim K et al. MMP-9 facilitates selective proteolysis of the histone H3 tail at genes necessary for proficient osteoclastogenesis. Genes Dev., 2016, 30: 208-219

[18] Kim K, Shin Y, Kim J, Ulmer TS, An W. H3K27me1 is essential for MMP-9-dependent H3N-terminal tail proteolysis during osteoclastogenesis. Epigenetics Chromatin, 2018, 11: 23

[19] Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet., 2012, 13: 343-357

[20] Kooistra SM, Helin K. Molecular mechanisms and potential functions of histone demethylases. Nat. Rev. Mol. Cell Biol., 2012, 13: 297-311

[21] Strobl-Mazzulla PH, Sauka-Spengler T, Bronner-Fraser M. Histone demethylase JmjD2A regulates neural crest specification. Dev. Cell, 2010, 19: 460-468

[22] Wang J et al. The histone demethylase JMJD2C is stage-specifically expressed in preimplantation mouse embryos and is required for embryonic development. Biol. Reprod., 2010, 82: 105-111

[23] Ye L et al. Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs. Cell Stem Cell, 2012, 11: 50-61

[24] Labbe RM, Holowatyj A, Yang ZQ. Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential. Am. J. Transl. Res., 2013, 6: 1-15

[25] Agger K et al. The KDM4/JMJD2 histone demethylases are required for hematopoietic stem cell maintenance. Blood, 2019, 134: 1154-1158

[26] Wu MC et al. KDM4B is a coactivator of c-Jun and involved in gastric carcinogenesis. Cell Death Dis., 2019, 10: 68

[27] Iwamori N, Zhao M, Meistrich ML, Matzuk MM. The testis-enriched histone demethylase, KDM4D, regulates methylation of histone H3 lysine 9 during spermatogenesis in the mouse but is dispensable for fertility. Biol. Reprod., 2011, 84: 1225-1234

[28] Wilson C, Krieg AJ. KDM4B: a nail for every hammer? Genes, 2019, 10: 134

[29] Pedersen MT, Helin K. Histone demethylases in development and disease. Trends Cell Biol., 2010, 20: 662-671

[30] Kawazu M et al. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS ONE, 2011, 6

[31] Fujiwara K et al. Deletion of JMJD2B in neurons leads to defective spine maturation, hyperactive behavior and memory deficits in mouse. Transl. Psychiatry, 2016, 6

[32] Uribe RA, Buzzi AL, Bronner ME, Strobl-Mazzulla PH. Histone demethylase KDM4B regulates otic vesicle invagination via epigenetic control of Dlx3 expression. J. Cell Biol., 2015, 211: 815-827

[33] Das PP et al. Distinct and combinatorial functions of Jmjd2b/Kdm4b and Jmjd2c/Kdm4c in mouse embryonic stem cell identity. Mol. Cell, 2014, 53: 32-48

[34] Lee HL, Yu B, Deng P, Wang CY, Hong C. Transforming growth factor-beta-induced KDM4B promotes chondrogenic differentiation of human mesenchymal stem cells. Stem Cells, 2016, 34: 711-719

[35] Choi JH, Song YJ, Lee H. The histone demethylase KDM4B interacts with MyoD to regulate myogenic differentiation in C2C12 myoblast cells. Biochem. Biophys. Res. Commun., 2015, 456: 872-878

[36] Cheng Y et al. KDM4B protects against obesity and metabolic dysfunction. Proc. Natl Acad. Sci. USA, 2018, 115: E5566-E5575

[37] Kang C et al. JMJD2B/KDM4B inactivation in adipose tissues accelerates obesity and systemic metabolic abnormalities. Genes Cells, 2018, 23: 767-777

[38] Coffey K et al. The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover. Nucleic Acids Res., 2013, 41: 4433-4446

[39] Shi L et al. Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc. Natl Acad. Sci. USA, 2011, 108: 7541-7546

[40] Hoffmann A, Spengler D. Chromatin remodeling complex NuRD in neurodevelopment and neurodevelopmental disorders. Front. Genet., 2019, 10: 682

[41] Kim JH et al. CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Mol. Cell, 2008, 31: 510-519

[42] Masliah-Planchon J, Bieche I, Guinebretiere JM, Bourdeaut F, Delattre O. SWI/SNF chromatin remodeling and human malignancies. Annu. Rev. Pathol., 2015, 10: 145-171

[43] Seo WY et al. CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2. Nucleic Acids Res., 2013, 41: 8526-8536

[44] Rishi AK et al. Identification and characterization of a cell cycle and apoptosis regulatory protein-1 as a novel mediator of apoptosis signaling by retinoid CD437. J. Biol. Chem., 2003, 278: 33422-33435

[45] Sumitomo A et al. The transcriptional mediator subunit MED1/TRAP220 in stromal cells is involved in hematopoietic stem/progenitor cell support through osteopontin expression. Mol. Cell Biol., 2010, 30: 4818-4827

[46] Beyer S, Kristensen MM, Jensen KS, Johansen JV, Staller P. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J. Biol. Chem., 2008, 283: 36542-36552

[47] Wilson C et al. The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer. Oncogene, 2017, 36: 2565-2576

[48] Han F et al. JMJD2B is required for Helicobacter pylori-induced gastric carcinogenesis via regulating COX-2 expression. Oncotarget, 2016, 7: 38626-38637

[49] Hung KH et al. The KDM4A/KDM4C/NF-kappaB and WDR5 epigenetic cascade regulates the activation of B cells. Nucleic Acids Res., 2018, 46: 5547-5560

[50] Vaira S et al. RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. J. Clin. Investig., 2008, 118: 2088-2097

[51] Castellini L et al. KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage. Nucleic Acids Res., 2017, 45: 3674-3692

[52] Yang J et al. The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth. Cancer Res., 2010, 70: 6456-6466

[53] Ipenberg I, Guttmann-Raviv N, Khoury HP, Kupershmit I, Ayoub N. Heat shock protein 90 (Hsp90) selectively regulates the stability of KDM4B/JMJD2B histone demethylase. J. Biol. Chem., 2013, 288: 14681-14687

[54] Johmura Y et al. Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer. J. Clin. Investig., 2018, 128: 5603-5619

[55] Qi Q et al. Histone demethylase KDM4A regulates adipogenic and osteogenic differentiation via epigenetic regulation of C/EBPalpha and canonical Wnt signaling. Cell Mol. Life Sci., 2020, 77: 2407-2421

[56] An D, Kim K, Lu W. Defective entry into mitosis 1 (Dim1) negatively regulates osteoclastogenesis by inhibiting the expression of nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (NFATc1). J. Biol. Chem., 2014, 289: 24366-24373

[57] Dempster DW et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res., 2013, 28: 2-17